1:17 PM
Feb 11, 2019
 |  BC Innovations  |  Distillery Therapeutics



In vitro and rat studies identified a benzimidazole-based PTGER4 antagonist that could help treat pain. High throughput screening of Bayer AG's compound library, in vitro enzymatic activity assays and optimization of hits yielded a benzimidazolecarboxylic acid-based compound (BAY 1316957)...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >